| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b1dae628278f95857080c16f9489999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f65000462732b10476ce5c6722079716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-538 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-538 |
| filingDate |
2011-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_296f00402e4a0fd27d57fb536ec547d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35f251e520fd5ef1d5644ace62a43146 |
| publicationDate |
2012-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012034275-A1 |
| titleOfInvention |
Powder formulations for inhalation, comprising enantiomerically pure beta agonists |
| abstract |
The present invention relates to powder formulations for inhalation containing enantiomerically pure compounds of general formula 1 n n n n n n n n n n wherein the groups R 1 , R 2 , R 3 and R 4 may have the meanings given in the claims and in the specification, optionally in the form of the pharmaceutically acceptable acid addition salts thereof, as well as optionally in combination with a pharmaceutically acceptable excipient, processes for preparing them and their use as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420809-B2 |
| priorityDate |
2004-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |